Industry News: Keynote Speakers Announced for SBS 17th Annual Conference & Exhibition

05 Jan 2011

The Society for Biomolecular Sciences, now officially the Biomolecular Sciences Section of the Society for Laboratory Automation and Screening (SLAS), announces three outstanding keynote speakers for the SBS 17th Annual Conference & Exhibition, the foremost international conference and exhibition focused on drug discovery and screening.

The following industry-leading professionals will present their insights at SBS 2011:

• Robert J. Lefkowitz, M.D.; Professor, Duke University School of Medicine
Beta Arrestin Mediated Signaling by 7 Transmembrane Receptors: New Therapeutic Opportunities

• Hugh Rosen, M.D., Ph.D.; Professor of Chemical Physiology, The Scripps Research Institute
Allostery and S1P Receptors: A Syzygy of Pharmacology and High-Resolution Crystal Structure

• Brian Shoichet, Ph.D.; Professor, Department of Pharmaceutical Chemistry, University of California, San Francisco
Mechanism and Effects of Colloidal Aggregation in Early Discovery and Drug Pharmacology

“These powerful SBS 2011 keynote speakers underscore our commitment to enhancing the scientific program by providing firsthand insight into featured topics,” said Michelle Palmer, SLAS President. “The knowledge these industry-leading scientists will provide help SLAS reach new heights of improving the conference’s value to participants and exhibitors, and offer glimpses into the future of drug discovery and screening.”